STOCK TITAN

Inspire Medical Systems: D. E. Shaw reports 4.2% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. (INSP) is the issuer in an amended Schedule 13G reporting D. E. Shaw & Co., L.P.’s beneficial ownership of 1,221,106 common shares, or 4.2% of the class. David E. Shaw may be deemed to beneficially own the same shares through shared authority, but he disclaims beneficial ownership and states that he owns no shares directly. The reporting persons report shared voting power over 1,141,539 shares and shared dispositive power over 1,221,106 shares.

Beneficial ownership 1,221,106 shares D. E. Shaw & Co., L.P.; 4.2% of the class
Ownership percentage 4.2% Reported for D. E. Shaw & Co., L.P. and David E. Shaw
Shared voting power 1,141,539 shares Reported by both reporting persons
Shared dispositive power 1,221,106 shares Reported by both reporting persons
beneficial ownership regulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared power to vote or to direct the vote"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared power to dispose or to direct the disposition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INSP shares did D. E. Shaw report owning?

D. E. Shaw & Co., L.P. reported beneficial ownership of 1,221,106 INSP common shares, equal to 4.2% of the class. The reported amount comprises shares held in three D. E. Shaw portfolio entities and shares under the management of D. E. Shaw Investment Management, L.L.C.

Does David E. Shaw directly own the reported INSP shares?

No. The statement says David E. Shaw does not own any shares directly and disclaims beneficial ownership of the 1,221,106 shares attributed to him through shared powers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





457730109

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



D. E. Shaw & Co., L.P.
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:11/16/2026
David E. Shaw
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Attorney-in-Fact for David E. Shaw
Date:11/16/2026

Comments accompanying signature: Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
Exhibit Information

Exhibit 2: Joint Filing Agreement, by and among the Reporting Persons, dated November 16, 2026.

Keep reading